James Hardie Industries plc filings document foreign-issuer disclosure for an Irish building-products company listed on the NYSE and ASX. Recent Form 6-K reports furnish ASX announcements, earnings-release timing, annual general meeting materials, voting results, substantial-holder notices, director interest notices and securities quotation or unquoted-security notifications.
The filing record ties governance and ownership disclosures to the company’s board, substantial holdings and equity-security activity, while periodic communications describe results reporting, forward-looking statement legends and the company’s exterior home and outdoor living products portfolio. These records also identify the company as an Irish public limited company governed under the Irish Companies Act.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. HECKES HOWARD C reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director Howard C. Heckes received an award of 1,268 ordinary shares on September 15, 2026 under the company’s Non-Executive Director Compensation Program. Following this award, he holds 29,151 ordinary shares directly, plus additional shares held indirectly through a trust for which he serves as trustee.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. Pfeifer John C reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director John C. Pfeifer received a grant of 751 ordinary shares on September 15, 2026, issued at $0.00 per share pursuant to the issuer's Non-Executive Director Compensation Program. Following this award, Pfeifer directly holds 6,112 ordinary shares. No Rule 10b5-1 trading plan is reported for this transaction.
James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. Sindel Alan Robert Harold reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc (JHX) reported that director Alan Robert Harold Sindel received a grant of 1,224 ordinary shares on September 15, 2026 under the company’s Non-Executive Director Compensation Program. The award was recorded at $0.00 per share, bringing his directly held position to 1,714 ordinary shares.
James Hardie Industries plc (JHX) reported insider equity transactions by Jonathan Skelly, President of James Hardie NA. On 2026-08-25 he exercised 50,000 employee stock options with an exercise price of $11.23 per share, which had been assumed in connection with the acquisition of The AZEK Company Inc. and were exercisable as of July 1, 2025. He then sold a total of 65,000 ordinary shares in open-market transactions at weighted average prices of approximately $30.45 and $30.46 per share, including 50,000 shares sold through a broker-assisted cashless exercise. Following the derivative transaction, he held 287,721 employee stock options directly.
James Hardie Industries plc (JHX) is the issuer for which officer Jonathan Skelly has filed a notice of proposed sale of up to 65,000 shares of common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,979,094.56 as of the notice date. The 65,000 shares consist of 15,000 shares acquired in a merger on 07/02/2025 and 50,000 shares acquired through a stock option exercise on 08/25/2026, both from the issuer. Shares outstanding were 580,522,488 as of 08/25/2026; this is a baseline figure, not the amount being sold.
James Hardie Industries plc (JHX) director Jesse G. Singh reported multiple option exercises and related share sales. On August 21 and 24, 2026, he exercised in total 530,100 employee stock options at an exercise price of $11.23 per share, receiving the same number of ordinary shares. The filing shows aggregate sales of 871,557 ordinary shares at weighted-average prices around $30 per share, including broker-assisted cashless exercises and sales by trusts for which Singh or his spouse serve as trustee or grantor-trustee.
James Hardie Industries plc (symbol JHX) received a notice that director Jesse Singh, through Goldman Sachs & Co. LLC as broker, plans to sell up to 120,000 shares of common stock under Rule 144, with an aggregate market value of $3,624,000, on or about August 24, 2026 on the NYSE. These shares were acquired from the issuer on July 2, 2025 as compensation in the form of restricted stock units. The notice also reports two prior sales on August 21, 2026 of 118,057 shares for $3,578,233.88 and 103,400 shares for $3,121,085.32.
James Hardie Industries plc (JHX) received a notice under Rule 144 for proposed sales of its common stock by director Jesse G. Singh. The notice lists a planned sale related to a stock option exercise involving 265,100 shares of common stock, with a proposed sale date of 08/24/2026. It also reports that during the past three months, Singh sold 265,000 common shares for aggregate proceeds of 8,001,542.50 on 08/21/2026. Fidelity Brokerage Services LLC signed the notice as attorney-in-fact for Singh.
James Hardie Industries plc (JHX) reported an equity compensation grant to CEO and director Aaron M. Erter. On 2026-08-20, he received 60,588 ordinary shares in the form of restricted stock units that vest in three equal annual installments beginning on June 15, 2027, subject to continued service. On the same date he was also granted 75,495 non-qualified stock options with a $25.17 exercise price, expiring on 2036-08-20 and vesting in three equal annual installments beginning on June 15, 2027. Following the RSU grant, he directly held 225,181 ordinary shares.
James Hardie Industries plc (symbol JHX) received a Rule 144 notice covering proposed sales of its common stock for the account of director Jesse Singh, with Goldman Sachs & Co. LLC acting as broker. The notice reports 221,457 shares of common stock, with an aggregate market value of $6,738,936.51, and 580,336,768 shares outstanding as of August 21, 2026; this is a baseline figure, not the amount being sold. Planned sales include 103,400 shares to be sold by the Jesse Singh 2024 GRAT and additional shares to be sold by the Jesse Singh 2016 Irrevocable Trust, all on the NYSE.